adenosine deaminase inhibitors

Preferred Label : adenosine deaminase inhibitors;

MeSH definition : Drugs that inhibit ADENOSINE DEAMINASE activity.;

MeSH synonym : deaminase inhibitors, adenosine; inhibitors, adenosine deaminase; ADA inhibitors; inhibitors, ADA;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D058892;

UMLS CUI

C2746041;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Adenosine deaminase inhibitor (disposition) [SNOMED CT concept]
- Substance with adenosine deaminase inhibitor mechanism of action (substance) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Adenosine Deaminase Inhibitor [NCIt concept]
MeSH Descriptor(s) used for indexing
- adenosine deaminase [MeSH Descriptor]
Record concept(s)
- adenosine deaminase inhibitors [MeSH concept]
See also (suggested by CISMeF)
- adenosine deaminase [MeSH Descriptor]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- (1-hydroxyethyl)-5-methyl-1-beta-ribofuranosylimidazole [MeSH Supplementary Concept]
- (2R,3S)-3-(4-Amino-1H-imidazo(4,5-c)pyridin-1-yl)-2-nonanol [MeSH Supplementary Concept]
- 1,3-dideaza-9-(2-hydroxy-3-nonyl)adenine [MeSH Supplementary Concept]
- 1,6-dihydro-6-(hydroxymethyl)-9-(2-hydroxy-3-nonyl)purine [MeSH Supplementary Concept]
- 1-(2-hydroxy-3-nonyl)-1,2,4-triazole [MeSH Supplementary Concept]
- 1-(2-hydroxy-3-nonyl)-1,2,4-triazole-3-carboxamide [MeSH Supplementary Concept]
- 1-(2-hydroxy-3-nonyl)imidazole-4-carboxamide [MeSH Supplementary Concept]
- 1-(4-(5-(3-(4-chlorophenyl)propoxy)-1-methylindol-3-yl)-1-hydroxy-2-butyl)imidazole-4-carboxamide [MeSH Supplementary Concept]
- 2-(2-hydroxydecyl)-4-aminopyrazolo(3,4-d)pyrimidine [MeSH Supplementary Concept]
- 3,6,7,8-tetrahydro-3-((2-hydroxyethoxy)methyl)imidazo(4,5-d)(1,3)diazepin-8-ol [MeSH Supplementary Concept]
- 5-(formylamino)imidazole riboside [MeSH Supplementary Concept]
- 7-deaza-9-(2-hydroxy-3-nonyl)adenine [MeSH Supplementary Concept]
- 9-(1-hydroxy-2-octyl)adenine [MeSH Supplementary Concept]
- 9-(2-hydroxy-3-nonyl)-1-deazaadenine [MeSH Supplementary Concept]
- adechlorin [MeSH Supplementary Concept]
- adecypenol [MeSH Supplementary Concept]
- elapegademase [MeSH Supplementary Concept]
- pentostatin [MeSH Descriptor]
UMLS correspondences (same concept)
- Adenosine Deaminase Inhibitor [NCIt concept]
- Substance with adenosine deaminase inhibitor mechanism of action (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients